These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Guideline of the diagnosis and treatment of eosinophilic disorders (2024)]. Leukemia and Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):1-7. PubMed ID: 38527831 [TBL] [Abstract][Full Text] [Related]
23. [Hematological disorders and hypereosinophilias]. Malfuson JV; Fagot T; Konopacki J; Mangouka L; Souleau B; de Revel T Rev Med Interne; 2009 Apr; 30(4):322-30. PubMed ID: 19201511 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies. Odinius TO; Buschhorn L; Wagner C; Hauch RT; Dill V; Dechant M; Buck MC; Shoumariyeh K; Moog P; Schwaab J; Reiter A; Brockow K; Götze K; Bassermann F; Höckendorf U; Branca C; Jost PJ; Jilg S J Cancer Res Clin Oncol; 2022 Feb; 148(2):331-340. PubMed ID: 34654952 [TBL] [Abstract][Full Text] [Related]
25. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Valent P Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139 [TBL] [Abstract][Full Text] [Related]
27. Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis. Gotlib J Curr Hematol Malig Rep; 2015 Dec; 10(4):351-61. PubMed ID: 26404639 [TBL] [Abstract][Full Text] [Related]
28. Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia. Lierman E; Cools J Expert Rev Anticancer Ther; 2009 Sep; 9(9):1295-304. PubMed ID: 19761433 [TBL] [Abstract][Full Text] [Related]
29. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495 [TBL] [Abstract][Full Text] [Related]
32. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. Cilloni D; Messa F; Martinelli G; Gottardi E; Arruga F; Defilippi I; Carturan S; Messa E; Fava M; Giugliano E; Rosso V; Catalano R; Merante S; Nicoli P; Rondoni M; Ottaviani E; Soverini S; Tiribelli M; Pane F; Baccarani M; Saglio G Leukemia; 2007 Jul; 21(7):1442-50. PubMed ID: 17508006 [TBL] [Abstract][Full Text] [Related]
33. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Tefferi A; Thiele J; Vardiman JW Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396 [TBL] [Abstract][Full Text] [Related]
34. The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review. Szymczyk A; Jaworski J; Podhorecka M Cent Eur J Immunol; 2024; 49(1):60-69. PubMed ID: 38812609 [TBL] [Abstract][Full Text] [Related]
35. A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia. Kalac M; Quintás-Cardama A; Vrhovac R; Kantarjian H; Verstovsek S Cancer; 2007 Sep; 110(5):955-64. PubMed ID: 17654661 [TBL] [Abstract][Full Text] [Related]
36. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1. Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675 [TBL] [Abstract][Full Text] [Related]
37. A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA. Zanelli M; Smith M; Zizzo M; Carloni A; Valli R; De Marco L; Foroni M; Palicelli A; Martino G; Ascani S BMC Pulm Med; 2019 Nov; 19(1):216. PubMed ID: 31744552 [TBL] [Abstract][Full Text] [Related]
38. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Valent P; Klion AD; Roufosse F; Simon D; Metzgeroth G; Leiferman KM; Schwaab J; Butterfield JH; Sperr WR; Sotlar K; Vandenberghe P; Hoermann G; Haferlach T; Moriggl R; George TI; Akin C; Bochner BS; Gotlib J; Reiter A; Horny HP; Arock M; Simon HU; Gleich GJ Allergy; 2023 Jan; 78(1):47-59. PubMed ID: 36207764 [TBL] [Abstract][Full Text] [Related]
39. Eosinophilic Myocarditis. Cheung CC; Constantine M; Ahmadi A; Shiau C; Chen LYC Am J Med Sci; 2017 Nov; 354(5):486-492. PubMed ID: 29173361 [TBL] [Abstract][Full Text] [Related]
40. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement. Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]